Table 4.
NETRIN1-PRS |
Genomic-PRS |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Effect Size, β | SD | t Value | p Value | p Value, FDR Corrected | R2a | Effect Size, β | SD | t Value | p Value | p Value, FDR Corrected | R2a | |
gMD | .028 | 0.011 | 2.417 | .016 | .031 | .076 | .034 | .011 | 2.924 | .003 | .007 | .111 |
Association Fibers | .022 | 0.012 | 1.897 | .058 | .077 | .048 | .042 | .012 | 3.591 | .000 | .001b | .172 |
Thalamic Radiations | .030 | 0.011 | 2.785 | .005 | .021b | .089 | .013 | .011 | 1.232 | .218 | .218 | .017 |
Projection Fibers | .021 | 0.012 | 1.766 | .077 | .077 | .045 | .029 | .012 | 2.380 | .017 | .023b | .081 |
FDR, false discovery rate; Genomic-PRS, polygenic risk score derived from the whole genome, excluding NETRIN1 pathway genes; gMD, global mean diffusivity; NETRIN1-PRS, polygenic risk score derived from the NETRIN1 signaling pathway; PRS, polygenic risk score.
R2 is the estimate of variance explained by each pathway, in %.
Statistically significant p values after false discovery rate correction.